Regarding functional assays, an increase in peripheral blood mononuclear cells’ proliferation and IFN-γ production with specific tumor lysate was detected in DCV-treated samples compared with basal ones in 69% (p  =  0.03) and 74% (p  =  0.15) of the patients, respectively. The gene discussed is IFNG; the disease is neoplasm.